RJFSA
CLB icon

Raymond James Financial Services Advisors’s Core Laboratories CLB Stock Holding History

Raymond James Financial Services Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,052
Closed -$204K – 2901
2020
Q2 		$204K Sell
10,052
-657
-6% -$11.8K ﹤0.01% 2484
2020
Q1 		$111K Sell
10,709
-3,140
-23% -$87.8K ﹤0.01% 2216
2019
Q4 		$522K Buy
+13,849
New +$622K ﹤0.01% 1953

Other funds holding CLB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $4.29B AUM 4.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Raymond James Financial Services Advisors's CLB Position: Q3 2020 in Review

Raymond James Financial Services Advisors sold out of Core Laboratories (CLB) in Q3 2020, closing a stake of 10,052 shares — an estimated $204K sold.

Raymond James Financial Services Advisors first reported a position in CLB in Q4 2019 and held it in 3 quarters. The position peaked at $522K in Q4 2019. 187 funds tracked by Wall St. Rank hold CLB as of Q3 2020.

  • Raymond James Financial Services Advisors reported no remaining Core Laboratories position as of Q3 2020 after selling out during the quarter.
  • Raymond James Financial Services Advisors sold 10,052 Core Laboratories shares in Q3 2020, an estimated $204K.
  • Raymond James Financial Services Advisors first reported a position in Core Laboratories in Q4 2019 and held it in 3 quarters.
  • Raymond James Financial Services Advisors's Core Laboratories position peaked at $522K in Q4 2019.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2020.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2020, filed 4 Nov 2020.